Related Experiment Video

Updated: Jul 17, 2026

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

Somatic mutations of the beta-TrCP gene in gastric cancer

Chang Jae Kim1, Jae Hwi Song, Yong Gu Cho

  • 1Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea.

APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|February 14, 2007
PubMed

Insights

Genetic alterations in the beta-transducin repeat-containing protein (beta-TrCP) gene may drive gastric cancer development. Mutations in beta-TrCP were found to stabilize beta-catenin, a key signaling molecule.

Area of Science:

  • Molecular biology
  • Oncology
  • Genetics

Background:

  • Beta-transducin repeat-containing protein (beta-TrCP) is a ubiquitin ligase component that negatively regulates Wnt/beta-catenin signaling by targeting beta-catenin for degradation.
  • Dysregulation of Wnt/beta-catenin signaling is implicated in various cancers, including gastric cancer.

Purpose of the Study:

  • To investigate the role of somatic mutations in the beta-TrCP gene in the development and progression of gastric cancer.
  • To determine if alterations in beta-TrCP correlate with beta-catenin levels in gastric tumors.

Main Methods:

  • Analysis of somatic mutations in the beta-TrCP gene in 95 gastric cancer samples using single-strand conformational polymorphism and sequencing.
  • Immunohistochemical staining to assess beta-catenin expression (cytoplasmic and nuclear) in tumor tissues.

Main Results:

  • Five missense mutations in the beta-TrCP gene (A99V, H342Y, H425Y, C206Y, G260E) were identified in 5.3% of the gastric cancers analyzed.
  • Tumor tissues with beta-TrCP mutations exhibited moderate to strong cytoplasmic and/or nuclear staining for beta-catenin.

Conclusions:

  • Somatic mutations in the beta-TrCP gene may contribute to gastric cancer development.
  • These mutations likely promote gastric tumorigenesis by stabilizing beta-catenin, thereby enhancing Wnt/beta-catenin signaling.

More Related Videos

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...